What is EnginZyme?
EnginZyme is at the forefront of sustainable manufacturing, aiming to make biobased technology accessible across diverse industries. The company's core innovation lies in its patented cell-free technology platform, which harnesses the catalytic power of enzymes. By merging biological processes with chemical industry efficiencies, EnginZyme offers a dual-benefit solution. This approach seeks to replace traditional fossil-fuel-based production methods, thereby accelerating the transition to greener manufacturing practices for essential modern products.
How much funding has EnginZyme raised?
EnginZyme has raised a total of $35.3M across 2 funding rounds:
Series A
$13M
Series B
$22.3M
Series A (2021): $13M with participation from Sofinnova Partners, SEB Greentech, and Industrifonden
Series B (2022): $22.3M led by Sofinnova Partners and Industrifonden
Key Investors in EnginZyme
Sofinnova Partners
Sofinnova Partners is a leading European venture capital firm specializing in life sciences, with a strong focus on healthcare and sustainability. They are known for their hands-on approach, acting as company builders across the entire value chain of life sciences investments, from seed to later stages.
Industrifonden
Industrifonden is a Swedish venture capital fund that invests in unique, scalable innovations aimed at improving society through breakthrough technologies and science, particularly in deep tech, life sciences, and transformative tech.
SEB Greentech
SEB Greentech is an investor focused on supporting environmentally conscious technologies and sustainable business models, contributing to the green transition within various industries.
What's next for EnginZyme?
The recent major strategic investment positions EnginZyme for accelerated growth and market penetration. With a focus on scaling its patented enzyme technology, the company is poised to further disrupt conventional chemical production. Future endeavors will likely concentrate on expanding its application across various sectors, forging new partnerships, and optimizing its biobased solutions to meet increasing global demand for sustainable alternatives. This strategic financing is expected to fuel further research and development, solidifying EnginZyme's role as a key player in the green chemistry revolution.
See full EnginZyme company page
